Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ann Thorac Surg ; 110(3): 1055-1059, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32339506

RESUMO

PURPOSE: There is a high incidence of complications after conventional open thoracic aortic arch replacement. Stent graft thoracic endovascular repair for aortic aneurysms has few complications. Vascular variability of the aortic arch branch is high and individualized aortic arch stent graft is required. We present our experience using 3-dimensional print-assisted fabrication of individualized stent grafts. DESCRIPTION: According to the patient's computed tomography angiography results before surgery, the aortic arch was printed 3-dimensionally and then an individualized stent graft was sewn. The prepared stents were placed in the descending aorta and the partial branches of the arch, and then released. EVALUATION: Intraoperative stent placement was successful. The deep hypothermic circulatory arrest time was only 5 minutes. The patient recovered well after surgery and no neurological complications occurred. Postoperative computed tomography angiography showed good stent expansion and no endoleak. CONCLUSIONS: Three-dimensional printing-assisted fabrication of a stent graft can be used for endovascular repair of the total aortic arch. This technology can be employed to construct individualized aortic arch stents accurately for different patients before surgery.


Assuntos
Aorta Torácica/cirurgia , Aneurisma da Aorta Torácica/cirurgia , Dissecção Aórtica/cirurgia , Procedimentos Endovasculares/métodos , Procedimentos de Cirurgia Plástica/métodos , Impressão Tridimensional , Stents , Dissecção Aórtica/diagnóstico , Aorta Torácica/diagnóstico por imagem , Aneurisma da Aorta Torácica/diagnóstico , Prótese Vascular , Angiografia por Tomografia Computadorizada , Humanos , Masculino , Pessoa de Meia-Idade , Desenho de Prótese
2.
J Cardiothorac Surg ; 14(1): 180, 2019 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-31647015

RESUMO

BACKGROUND: The traditional approach for adult congenital heart disease combined with valvular disease is surgical treatment under cardiopulmonary bypass (CPB). This approach has a high incidence of postoperative complications, especially in patients with pulmonary hypertension and old age. We present two patients in whom the hybrid procedure was used to treat congenital malformations, followed by valve formation and replacement surgery. CASE PRESENTATION: A 63-year-old man had a muscular ventricular septal defect complicated by mitral regurgitation and a 57-year-old man had patent ductus arteriosus complicated by aortic stenosis. In both of the patients, the congenital malformation was successfully treated by the hybrid procedure, followed by valve repair or replacement. Both patients had no complications. A post-procedure echocardiogram showed no residual shunt across the duct. CONCLUSIONS: Our findings suggest that the hybrid procedure is a useful alternative for treating adult congenital heart disease with valvular heart disease. This procedure reduces the surgical incision and difficulty of surgery, shortens the CPB time, avoids residual leakage after surgery, and reduces recovery and hospitalization times.


Assuntos
Cardiopatias Congênitas/cirurgia , Doenças das Valvas Cardíacas/cirurgia , Estenose da Valva Aórtica/complicações , Ponte Cardiopulmonar , Permeabilidade do Canal Arterial/cirurgia , Ecocardiografia , Cardiopatias Congênitas/complicações , Comunicação Interventricular/cirurgia , Doenças das Valvas Cardíacas/complicações , Hospitalização , Humanos , Hipertensão Pulmonar/complicações , Masculino , Pessoa de Meia-Idade , Insuficiência da Valva Mitral/complicações , Complicações Pós-Operatórias
3.
Adv Sci (Weinh) ; 5(12): 1801201, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30581711

RESUMO

The exploitation of smart nanoagents based drug delivery systems (DDSs) has proven to be a promising strategy for fighting cancers. Hitherto, such nanoagents still face challenges associated with their complicated synthesis, insufficient drug release in tumors, and low cancer cell chemosensitivity. Here, the engineering of an adenosine triphosphate (ATP)-activatable nanoagent is demonstrated based on self-assembled quantum dots-phenolic nanoclusters to circumvent such challenges. The smart nanoagent constructed through a one-step assembly not only has high drug loading and low cytotoxicity to normal cells, but also enables ATP-activated disassembly and controlled drug delivery in cancer cells. Particularly, the nanoagent can induce cell ATP depletion and increase cell chemosensitivity for significantly enhanced cancer chemotherapy. Systematic in vitro and in vivo studies further reveal the capabilities of the nanoagent for intracellular ATP imaging, high tumor accumulation, and eventual body clearance. As a result, the presented multifunctional smart nanoagent shows enhanced antitumor efficacy by simultaneous ATP-responsive chemodrug release and cancer cell sensitization. These findings offer new insights toward the design of smart nanoagents for improved cancer therapeutics.

4.
Small ; 13(20)2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28383201

RESUMO

Smart assemblies have attracted increased interest in various areas, especially in developing novel stimuli-responsive theranostics. Herein, commercially available, natural tannic acid (TA) and iron oxide nanoparticles (Fe3 O4 NPs) are utilized as models to construct smart magnetic assemblies based on polyphenol-inspired NPs-phenolic self-assembly between NPs and TA. Interestingly, the magnetic assemblies can be specially disassembled by adenosine triphosphate, which shows a stronger affinity to Fe3 O4 NPs than that of TA and partly replaces the surface coordinated TA. The disassembly can further be facilitated by the acidic environment hence causing the remarkable change of the transverse relaxivity and potent "turn-on" of fluorescence (FL) signals. Therefore, the assemblies for specific and sensitive tumor magnetic resonance and FL dual-modal imaging and photothermal therapy after intravenous injection of the assemblies are successfully employed. This work not only provides understandings on the self-assembly between NPs and polyphenols, but also will open new insights for facilely constructing versatile assemblies and extending their biomedical applications.


Assuntos
Trifosfato de Adenosina/química , Hipertermia Induzida , Imageamento por Ressonância Magnética , Neoplasias/terapia , Imagem Óptica , Fototerapia , Polifenóis/fisiologia , Animais , Difusão Dinâmica da Luz , Fluorescência , Células Hep G2 , Humanos , Concentração de Íons de Hidrogênio , Raios Infravermelhos , Camundongos , Neoplasias/patologia , Soluções
5.
Nanoscale ; 9(8): 2718-2722, 2017 Feb 23.
Artigo em Inglês | MEDLINE | ID: mdl-28198899

RESUMO

Persistent luminescent nanoparticles (PLNPs) have emerged as important nanomaterials for biological imaging as a result of complete avoidance of tissue auto-fluorescence. However, the imaging sensitivity and long-term in vivo imaging are still limited due to the persistent luminescence that is rapidly decayed in vivo after an ex vivo excitation. To address this limitation, in vivo activation of PLNPs is highly desired. Herein, we present a new strategy for the activation of PLNPs (SrAl2O4:Eu2+) by using soft X-ray excitation. Importantly, as the soft X-ray light source possesses the advantage of deep tissue penetration, the PLNPs can be reactivated in vivo through living tissue using soft X-ray excitation. Furthermore, X-ray/persistent luminescence dual-modal imaging can be achieved to empower this strategy with high sensitivity. Our results suggest that this new strategy of in vivo energy charging in PLNPs would bring new insights for deep tissue and long-term bioimaging in living animals, and provide new perspectives for persistent luminescence bioimaging and therapeutic applications.


Assuntos
Luminescência , Nanopartículas , Neoplasias Experimentais/diagnóstico por imagem , Raios X , Animais , Células Hep G2 , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Radiografia
6.
Analyst ; 141(11): 3126-40, 2016 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-27146244

RESUMO

Metal nanoclusters (NCs) are emerging as a new class of functional nanomaterials in the area of biological sensing, labelling, imaging and therapy due to their unique physical and chemical properties, such as ultrasmall size, HOMO-LUMO transition, strong luminescence together with good photostability and biocompatibility. A recent surge of interest in this field is the surface functionalization of these metal NCs through which one can tailor their physicochemical properties, such as stability in solution, and strong luminescence, as well as their biodistribution and toxicity in biological systems, which in turn can empower these functionalized NCs with desirable targeting, imaging, and therapeutic ability for biomedical applications. In this review, we first introduce the functionalization strategies for the metal NCs developed in the past few years, followed by highlighting some biomedical applications of these functionalized metal NCs. We then discuss the difference of in vitro and in vivo fate as well as toxicity between various functionalized metal NCs. Finally, we present a short discussion on the current challenges and provide an outlook of the future developments of these functional metal NCs.


Assuntos
Nanopartículas Metálicas/química , Animais , Diagnóstico por Imagem , Portadores de Fármacos , Humanos , Luminescência , Fotoquimioterapia , Radioterapia , Distribuição Tecidual
7.
Small ; 12(11): 1506-13, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26763187

RESUMO

Theranostic nanomedicines that integrate diagnostic and therapeutic moieties into a single nanoscale platform are playing an increasingly important role in fighting cancer. Here, a facile and green synthetic strategy for hollow CoPt alloy nanoparticles (HCPA-NPs) using plant polyphenols as assisted agents is reported for the first time. This novel strategy enables size-controlled synthesis of HCPA-NPs through the control of the molecular sizes of polyphenols. It is also a versatile strategy for synthesizing other hollow alloy nanoparticles with various metal compositions due to the diverse metal-chelating ability of the polyphenols. Further studies show that HCPA-NPs have good biocompatibility and can be successfully implemented for magnetic resonance and photoacoustic dual-modal imaging guided photothermal therapy. This work brings new insights for the green synthesis of hollow nanoparticles and extends these biocompatible nanoparticles for theranostic applications.


Assuntos
Ligas/química , Química Verde/métodos , Hipertermia Induzida , Nanopartículas Metálicas/química , Imagem Multimodal , Fototerapia , Polifenóis/química , Animais , Sobrevivência Celular , Células HeLa , Células Hep G2 , Humanos , Células MCF-7 , Imageamento por Ressonância Magnética , Nanopartículas Metálicas/ultraestrutura , Camundongos , Polietilenoglicóis/química , Taninos/química
8.
Adv Mater ; 27(21): 3285-91, 2015 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-25885638

RESUMO

A new theranostic platform is developed based on biocompatible poly(acrylic acid) (PAA)-Co9 Se8 nanoplates. These PAA-Co9 Se8 nanoplates are successfully utilized for photoacoustic imaging (PAI)/magnetic resonance imaging (MRI) dual-modal imaging. Moreover, the PAA-Co9 Se8 -DOX shows pH-responsive chemotherapy and enables the combination of photothermal therapy and chemotherapy to receive superior antitumor efficacy. This work promises further exploration of 2D nanoplatforms for theranostic applications.


Assuntos
Cobalto , Imageamento por Ressonância Magnética/instrumentação , Nanoestruturas , Técnicas Fotoacústicas/instrumentação , Compostos de Selênio , Nanomedicina Teranóstica/instrumentação , Resinas Acrílicas/síntese química , Resinas Acrílicas/química , Antineoplásicos/administração & dosagem , Materiais Biocompatíveis/síntese química , Materiais Biocompatíveis/química , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos da radiação , Cobalto/química , Terapia Combinada/instrumentação , Terapia Combinada/métodos , Meios de Contraste/síntese química , Meios de Contraste/química , Células Hep G2 , Humanos , Concentração de Íons de Hidrogênio , Imageamento por Ressonância Magnética/métodos , Teste de Materiais , Imagem Multimodal/instrumentação , Imagem Multimodal/métodos , Nanoestruturas/química , Transplante de Neoplasias , Técnicas Fotoacústicas/métodos , Fototerapia/instrumentação , Fototerapia/métodos , Compostos de Selênio/síntese química , Compostos de Selênio/química , Nanomedicina Teranóstica/métodos
9.
Sci Rep ; 3: 1998, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23770650

RESUMO

Employing theranostic nanoparticles, which combine both therapeutic and diagnostic capabilities in one dose, has promise to propel the biomedical field toward personalized medicine. Here we investigate the theranostic properties of topological insulator bismuth selenide (Bi2Se3) in in vivo and in vitro system for the first time. We show that Bi2Se3 nanoplates can absorb near-infrared (NIR) laser light and effectively convert laser energy into heat. Such photothermal conversion property may be due to the unique physical properties of topological insulators. Furthermore, localized and irreversible photothermal ablation of tumors in the mouse model is successfully achieved by using Bi2Se3 nanoplates and NIR laser irradiation. In addition, we also demonstrate that Bi2Se3 nanoplates exhibit strong X-ray attenuation and can be utilized for enhanced X-ray computed tomography imaging of tumor tissue in vivo. This study highlights Bi2Se3 nanoplates could serve as a promising platform for cancer diagnosis and therapy.


Assuntos
Bismuto/química , Neoplasias Experimentais/diagnóstico , Neoplasias Experimentais/terapia , Selênio , Animais , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Microscopia Eletrônica de Transmissão , Selênio/química , Tomografia Computadorizada por Raios X , Difração de Raios X
10.
Artigo em Chinês | MEDLINE | ID: mdl-23072130

RESUMO

OBJECTIVE: To determine the kinetics of infection and cyst formation in CD1 mice following oral infection with cyst-forming Chinese isolate of Toxoplasma gondii TgCtwh1(genotype China 1, ToxoDB#9). METHODS: 50 CD1 female mice were obtained from specific pathogen-free (SPF) mouse colony in the Vital River Laboratories (VRL), Beijing. Mice were randomly divided into 10 groups each with 5 mice. All mice but control were peroral gavage infected with 50 cysts (1x10(4) bradyzoites) of TgCtwh1 isolate of T. gondii isolated from Wuhan, China. Cysts were isolated from the entire brain of mice infected with TgCtwh1 by density gradient centrifugation over Fycoll-paque plus. Animals were orally inoculated with cysts on day zero, and peripheral blood, lymph nodes, heart, liver, and brain of infected mice were collected on days 2, 4, 7, 10, 14, 21, 35, 50, and 72 post infection. Five mice were sacrificed by cervical dislocation under anesthesia at each time of collection, and the kinetic distribution was detected by fluorescence quantitative PCR and tissue inoculation into fresh mice. The cyst formation at various intervals after infection was also observed, as was the number of the cysts in brains and the cyst-forming rate. RESULTS: The body weight of the mice lessened (3.650 +/- 0.252)g post oral infection on day 7, and the weight was progressively decreased between day 10 [(1.730 +/- 0.017)g] and day 14 [(-0.390 +/- 0.554) g] after infection (P<0.05). In the brain tissue, cysts were first observed on day 21 post oral infection and the cyst-forming rate was 80%, and the average diameter of cysts was 20-40 microm. While on day 35 after infection, the cysts were formed in all infected mice(cyst-forming rate was 100%) and the average diameter was 50-60 microm. In chronic infection, DNA copies of parasites were first detected in blood, heart, liver and lymph node at 3.51 +/- 0.152, 4.100 +/- 0.198, 4.220 +/- 0.209 and 4.960 +/- 0.052 respectively on day 2, then in the brain on day 4 (3.800 +/- 0.154). During the early days of infection, the parasite burden in blood was progressively increased until days 7 (5.240 +/- 0.115) then gradually decreased and become undetectable on day 35. The burden of T. gondii in the heart and brain tissues increased significantly and reached their maximum on day 14 (5.640 +/- 0.214) and day 10 (5.790 +/- 0.060), respectively, and remained a stable level thereafter. Liver and lymph tissues reached their maximum on day 7 (5.310 +/- 0.038) and day 10 (6.200 +/- 0.152), then gradually decreased and become undetectable on day 50. CONCLUSION: The parasitemia in mice infected with T. gondii cyst-forming isolate lasts for 21 d at least, and cysts are detected in brain on day 21.


Assuntos
Encéfalo/parasitologia , Toxoplasma/isolamento & purificação , Toxoplasmose Animal/parasitologia , Animais , Feminino , Genes de Protozoários , Genótipo , Camundongos , Reação em Cadeia da Polimerase/métodos , Toxoplasma/genética
11.
Anal Chim Acta ; 749: 70-4, 2012 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-23036469

RESUMO

A simple turn-on and homogeneous aptasensor, which relies on target induced formation of silver nanoclusters (Ag NCs), was developed for the determination of platelet-derived growth factor B-chain homodimer (PDGF-BB). The aptasensor contains two hairpin DNA probes termed as P1 and P2. P1 consists of the aptamer sequence of PDGF-BB. Meanwhile, P2 contains the Ag NCs nucleation sequence, which is blocked by the hairpin stem region. P1 and P2 can co-exist metastably in the absence of PDGF-BB and maintain hairpin structure. However, in the presence of PDGF-BB, the binding of PDGF-BB with aptamer will result in the hybridization between P1 and P2, and release the Ag NCs nucleation sequence. In this case, Ag NCs can be formed via the reduction of Ag(+) by NaBH(4). By monitoring the increase in fluorescence intensity, we could detect the target protein with high sensitivity. The detection limit of this aptasensor is 0.37 nM, which is comparable with that of other reported aptasensors. Furthermore, this proposed aptasensor shows high selectivity toward its target protein. Thus, the proposed aptasensor based on target induced formation of Ag NCs could be used as a sensitive and selective platform for the detection of target protein.


Assuntos
Aptâmeros de Nucleotídeos/química , Nanopartículas Metálicas/química , Prata/química , Aptâmeros de Nucleotídeos/metabolismo , Becaplermina , Sequências Repetidas Invertidas , Proteínas Proto-Oncogênicas c-sis/análise , Espectrometria de Fluorescência
12.
Acta Trop ; 116(1): 1-8, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20451489

RESUMO

Schistosomiasis remains a major parasitic disease, with 200 million people infected and 779 million people at risk worldwide. The lack of reliable diagnostic techniques makes this disease difficult to control. In an attempt to discover useful candidates for the diagnosis of schistosomiasis, proteomics in combination with western blotting were employed in this study. This serological proteome assay yielded more than 30 immunodominant spots. Ten of these spots were precisely matched with a homologous two-dimensional electrophoresis (2-DE) gel and successfully identified by LC/MS-MS as corresponding to four different proteins. Of these proteins, SjLAP and SjFBPA were successfully expressed, and their recombinant protein products were further applied in the diagnosis of human Schistosomiasis japonica using ELISA. The ELISA results revealed sensitivities of 98.1% and 87.8% for acute and chronic schistosomiasis with rSjLAP and 100% and 84.7% with rSjFBPA, whereas the assays showed a specificity of 96.7% with both recombinant proteins. After treatment with praziquantel, the titres of the antibodies against both antigens declined significantly (P<0.001). Our data therefore suggest that these antibody-oriented recombinant proteins had a high efficacy for the diagnosis of S. japonica, and 2-DE based screening followed by LC/MS-MS has promising potential in the screening of candidate antigens for the diagnosis of schistosomiasis.


Assuntos
Antígenos de Helmintos , Proteínas de Helminto , Proteoma , Schistosoma japonicum/imunologia , Esquistossomose Japônica/diagnóstico , Animais , Anti-Helmínticos/farmacologia , Anticorpos Anti-Helmínticos , Antígenos de Helmintos/imunologia , Western Blotting/métodos , Cromatografia Líquida de Alta Pressão , Primers do DNA , Bases de Dados de Ácidos Nucleicos , Eletroforese em Gel Bidimensional/métodos , Ensaio de Imunoadsorção Enzimática/métodos , Proteínas de Helminto/sangue , Proteínas de Helminto/imunologia , Humanos , Epitopos Imunodominantes/imunologia , Praziquantel/farmacologia , Proteoma/análise , Proteoma/imunologia , Coelhos , Schistosoma japonicum/efeitos dos fármacos , Esquistossomose Japônica/sangue , Esquistossomose Japônica/tratamento farmacológico , Sensibilidade e Especificidade , Caramujos , Espectrometria de Massas em Tandem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA